2023
DOI: 10.1016/j.expneurol.2022.114255
|View full text |Cite
|
Sign up to set email alerts
|

Intrathecal minocycline does not block the adverse effects of repeated, intravenous morphine administration on recovery of function after SCI

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 111 publications
0
1
0
Order By: Relevance
“…However, studies have shown that morphine use can increase inflammation and mortality at the injured site, and minocycline pretreatment can not only reduce the number of macrophages at the lesion site, particularly pro-inflammatory macrophages, but also block the negative effects of morphine on functional recovery after injury [ 239 ]. However, the author's further studies demonstrated that minocycline could only prevent the harmful effects of a single intrathecal morphine injection but could not prevent the adverse effects of repeated morphine injections [ 240 ]. More research is needed to determine the viability of using it in conjunction with opioids to treat SCI.…”
Section: Advances and Challenges In Clinical Mirna Treatmentmentioning
confidence: 99%
“…However, studies have shown that morphine use can increase inflammation and mortality at the injured site, and minocycline pretreatment can not only reduce the number of macrophages at the lesion site, particularly pro-inflammatory macrophages, but also block the negative effects of morphine on functional recovery after injury [ 239 ]. However, the author's further studies demonstrated that minocycline could only prevent the harmful effects of a single intrathecal morphine injection but could not prevent the adverse effects of repeated morphine injections [ 240 ]. More research is needed to determine the viability of using it in conjunction with opioids to treat SCI.…”
Section: Advances and Challenges In Clinical Mirna Treatmentmentioning
confidence: 99%